High-dose-rate brachytherapy boost for elderly patients with intermediate to high-risk prostate cancer: 5-year clinical outcome of the PROSTAGE cohort

PURPOSE: To analyze the oncological outcome in elderly (>70 years) prostate cancer after high-dose rate brachytherapy (HDB) boost. MATERIALS/METHODS: In this retrospective study, patients with intermediate (IR) and high-risk (HR) prostate cancer underwent external beam radiation therapy (EBRT) fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Marotte, Delphine, Gal, Jocelyn, Schiappa, Renaud, Gautier, Mathieu, Boulahssass, Rabia, Chand-Fouche, Marie-Eve, Hannoun-Levi, Jean-Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184865/
https://www.ncbi.nlm.nih.gov/pubmed/35692263
http://dx.doi.org/10.1016/j.ctro.2022.05.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184865/
https://www.ncbi.nlm.nih.gov/pubmed/35692263
http://dx.doi.org/10.1016/j.ctro.2022.05.001

Ejemplares similares